STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Xiao, Ping, Meng, Fanlu, Zhong, Diansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601241/
https://www.ncbi.nlm.nih.gov/pubmed/36290807
http://dx.doi.org/10.3390/curroncol29100530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601241/
https://www.ncbi.nlm.nih.gov/pubmed/36290807
http://dx.doi.org/10.3390/curroncol29100530

Ejemplares similares